Document is current
Any future updates will be listed below
-
Authors
Jackson, Graham S.
Linehan, Jacqueline
Brandner, Sebastian
Asante, Emmanuel A.
Wadsworth, Jonathan D. F.
Collinge, John
-
Funding
Funding for this research was provided by:
Medical Research Council (Intramural, Intramural, Intramural, Intramural, Intramural, Intramural)
- License Information
-
More Information
Article History
Received: 19 October 2021
Accepted: 29 September 2022
First Online: 13 October 2022
Competing interests
: The authors declare that they have no conflicts of interest relevant to this manuscript, with the exceptions of: J.C. is a Director and G.S.J., J.D.F.W. and J.C. are shareholders of D-Gen Limited (London), an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen supplied the antibody ICSM35 used in this study.
